Sihuan Pharmaceutical signed a collaborative development agreement to develop a treatment for Ebola with the Institute of Microbiology and Epidemiology of China’s Academy of Military Medical Sciences (AMMS). The Institute discovered jk-0. Although the drug has been approved for military use, no clinical trials of jk-05 have been completed. Sihuan will pay a technology transfer fee of $1.6 million for rights to jk-05.
Help employers find you! Check out all the jobs and post your resume.
